HB3321 amends section 1905(y) of the Social Security Act to phase down the enhanced Federal Medical Assistance Percentage (FMAP) that currently finances Medicaid coverage for low‑income adults, moving states back to their regular FMAP by 2035. It also removes a separate temporary FMAP increase that applied to states beginning coverage for these adults.
The bill matters because it changes the federal‑state financial calculus that underpins the Affordable Care Act expansion. By reducing federal matching over an eight‑year schedule and denying enhanced match to states that expand after enactment, the bill reduces federal outlays but increases fiscal pressure on states, with direct implications for coverage, state budgets, hospitals, and managed care markets.
At a Glance
What It Does
The bill keeps the 90% enhanced match through 2026, then reduces that enhanced rate in annual steps from 2027 through 2034 using a per‑state formula, and restores the state's regular FMAP in 2035. It also repeals a separate temporary FMAP increase that applied to states that began providing coverage to newly eligible adults.
Who It Affects
The changes directly affect state Medicaid programs that cover low‑income adults under the ACA expansion (and states considering expansion), the federal budget, hospitals and safety‑net providers, Medicaid managed care plans, and low‑income adults eligible for Medicaid.
Why It Matters
The bill removes a key federal financial incentive for expansion and creates a predictable but uneven glidepath off the 90% match. That alters state incentives about whether and how to expand coverage, and it shifts fiscal risk from the federal government back to states and providers.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
HB3321 rewrites the current enhanced‑match rules that pay for Medicaid coverage for low‑income adults. Under current law, federal matching for newly eligible adults was set at 90 percent (or otherwise enhanced) for many years.
The bill preserves that 90 percent level only through calendar year 2026, and then establishes a multi‑year phase‑down from 2027 through 2034 that reduces the enhanced match annually before returning each State to its regular FMAP in 2035.
The phase‑down is not a uniform percentage each year. Instead, the bill computes, for each State, the difference between 90 percent and the State’s regular FMAP for fiscal year 2026, divides that gap by eight, and subtracts that number of percentage points each year from the enhanced rate beginning in 2027.
That produces an eight‑step glidepath where States with larger gaps from 90 percent will see larger per‑year reductions. The statutory language also includes application rules: States that had not expanded Medicaid coverage for newly eligible adults before enactment (so‑called "non‑expansion States") are not subject to the phase‑down language, and if such a State decides to expand on or after enactment it will not benefit from the enhanced phase‑down rates and will instead receive its regular FMAP.HB3321 gives existing expansion States one limited option: a State may choose to limit the populations it covers with expansion dollars to newly eligible adults with income at or below 100 percent of the Federal Poverty Level, and keep the phased enhanced match for that narrower group.
Finally, the bill deletes a separate temporary FMAP increase provision (section 1905(ii) in current law) that previously provided a transitional match boost to States that began providing coverage to low‑income adults. Removing that provision eliminates a prior policy lever designed to encourage late expansion.Taken together, the bill converts an open‑ended, high federal subsidy for adult coverage into a scheduled federal retreat.
That change reduces federal outlays but hands more budgetary exposure to States and to providers that serve Medicaid populations, while also changing the political and financial incentives that drive decisions on whether and how to expand coverage.
The Five Things You Need to Know
The bill preserves the 90% enhanced FMAP only through calendar year 2026 and then phases the enhancement down annually in calendar years 2027–2034, restoring each State’s regular FMAP in 2035.
For each State the annual reduction equals (90% minus the State’s regular FMAP for FY2026) divided by 8 — so States with a larger gap from 90% face larger per‑year cuts.
Paragraph (1) of the amended statute does not apply to a State that had not expanded coverage for newly eligible adults before enactment (a “non‑expansion State”); if such a State expands after enactment it will receive the State’s regular FMAP rather than the phased enhanced rate.
An expansion State may opt to limit expansion benefits to newly eligible adults with income at or below 100% of the Federal Poverty Level and retain the phased enhanced match for that subset of enrollees.
The bill strikes subsection 1905(ii) of the Social Security Act, eliminating a separate temporary FMAP increase that previously provided transitional federal matching to States that began covering newly eligible low‑income adults.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Provides the Act’s short name: "Ending Medicaid Discrimination Against the Most Vulnerable Act." This is a naming provision and carries no operative policy detail beyond identifying the bill.
End the 90% floor after 2026 and add a phased reduction schedule
Amends paragraph (1) of section 1905(y) to leave the enhanced 90% match in place through 2026 but then adds new subparagraphs (F) and (G) that create the phase‑down. Subparagraph (F) imposes annual reductions for calendar years 2027–2034 using a per‑State decrement, and subparagraph (G) sets calendar year 2035 and thereafter to the State’s regular FMAP. Practically, this converts the enhanced match from a permanent 90% floor into a temporary, diminishing subsidy over an eight‑year window.
State‑specific reduction formula
Adds a new paragraph (3) that defines the "applicable number of percentage points" used each year in the phase‑down: it equals the difference between 90% and the State’s regular FMAP for FY2026, divided by 8. That makes the annual reduction depend on the State’s baseline FMAP in FY2026, which produces unequal annual percentage‑point cuts across States. The provision effectively ties the glidepath to a single historical FMAP snapshot (FY2026), rather than to future changes in regular FMAP.
Rules for non‑expansion States and optional eligibility cap
Paragraph (4) contains application rules: it says the phase‑down does not apply to States that had not expanded coverage for newly eligible adults before enactment. If a non‑expansion State elects to expand on or after enactment, the State will receive its regular FMAP for amounts expended for those adults (i.e., it gets no phased enhanced match). It also permits expansion States to elect to limit expansion coverage to enrollees at or below 100% of the Federal Poverty Level and retain the phased enhanced match for that limited group, which creates a statutory option for States to narrow eligibility in order to preserve enhanced federal financing for a subset of enrollees.
Eliminate temporary FMAP boost for newly expanding States
Deletes subsection (ii) of section 1905, removing a temporary FMAP increase that previously applied to States that began providing coverage to newly eligible low‑income adults. The repeal eliminates a prior federal incentive designed to lower the short‑term cost of expansion for States that had not previously expanded.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Federal budget and fiscal policymakers — The phase‑down reduces long‑term federal Medicaid outlays relative to a permanent 90% match, producing direct federal savings and lowering future federal budget exposure for adult expansion costs.
- States with higher regular FMAPs (higher baseline match) — Because the per‑year reduction equals (90% minus the State’s FY2026 FMAP) divided by 8, States that already receive a relatively high regular FMAP (smaller gap from 90%) will see smaller absolute annual cuts, producing a gentler local fiscal transition.
- States that want to avoid expansion incentives — Non‑expansion States that prefer not to expand gain policy clarity: expanding after enactment will not trigger a temporary enhanced match, removing a financial inducement to expand.
- States that choose targeted coverage at ≤100% FPL — The bill explicitly allows an option to limit expansion eligibility to protect enhanced match for that subset, which may benefit States seeking to preserve federal funds while narrowing coverage.
Who Bears the Cost
- Low‑income adults covered under expansion — As federal matching phases down, States face pressure to reduce eligibility, benefits, or provider payments; that could lead to coverage losses, narrower benefit designs, or access constraints.
- State budgets and taxpayers — With lower federal matches, States must either increase their own spending to maintain coverage or absorb reductions; the phase‑down shifts fiscal burden back to States and localities.
- Safety‑net providers and hospitals — Reduced federal funding and potential coverage contractions can increase uncompensated care and pressure payment rates, risking financial strain for hospitals and clinics serving Medicaid populations.
- Medicaid managed care organizations and plans — Changing enrollment levels, state payment rates, and benefit structures add actuarial and operational uncertainty for plans that contract with states.
- Advocacy groups and local public health systems — Organizations relying on the stability of federal funding face programmatic and planning challenges if States trim coverage or providers cut services.
Key Issues
The Core Tension
The central dilemma is fiscal fairness versus coverage stability: HB3321 reduces federal spending and incentives for expansion (addressing concerns about open‑ended federal fiscal commitments) but does so by shifting cost and coverage risk to States, providers, and low‑income adults—forcing a choice between preserving federal savings and maintaining or expanding access to Medicaid.
The bill builds the phase‑down on a fixed FY2026 FMAP baseline and divides the gap from 90% into eight equal annual percentage‑point reductions. That design creates two implementation issues: first, using a historical FMAP snapshot freezes the distributional starting point and may produce unintended winners and losers if a State’s regular FMAP changes materially after FY2026 for unrelated reasons; second, unequal per‑year cuts (larger for States whose regular FMAP is further below 90%) mean the burden is not uniformly shared and could incentivize disparate policy responses across States.
The exemption and application rules add complexity. Defining "non‑expansion State" by whether the State expended amounts for the relevant population before enactment leaves open edge cases (partial expansions, coverage via waivers, or differing state accounting approaches) that could require federal guidance or litigation.
The statutory option that lets a State restrict expansion to enrollees at or below 100% of the FPL to preserve enhanced match for that group creates a sharp eligibility cliff at 100% FPL and invites administrative challenges (determining who qualifies, managing transitions, and avoiding churn). Finally, striking the temporary FMAP increase removes an explicit federal incentive for late expansion, which will likely reduce expansion interest but increase the uninsured population in non‑expansion States — a predictable policy trade‑off the bill accepts rather than mitigating.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.